# "Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells

> **NCT05751564** · PHASE2 · UNKNOWN · sponsor: **Universidad de los Andes, Chile** · enrollment: 60 (estimated)

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **BIOLOGICAL:** "Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product
- **BIOLOGICAL:** Resuspended Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product

## Key facts

- **NCT ID:** NCT05751564
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04
- **Primary completion:** 2024-12
- **Final completion:** 2025-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05751564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05751564, ""Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05751564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*